Quince Therapeutics Implements 1-for-10 Reverse Stock Split Effective April 10th

summarizeSummary

Quince Therapeutics, Inc. announced the implementation of a 1-for-10 reverse stock split, effective April 10, 2026, with split-adjusted trading commencing April 13, 2026.

check_boxKey Events

• Reverse Stock Split Implemented

  The Company's board of directors approved the implementation of a 1-for-10 reverse stock split, previously authorized by stockholders on June 4, 2025.

• Effective Date and Trading

  The reverse stock split will be effective at 11:59 pm Eastern Time on April 10, 2026, with shares beginning to trade on a split-adjusted basis on the Nasdaq Global Select Market upon market open on April 13, 2026.

• Impact on Shares and Derivatives

  Every ten shares of common stock will be combined into one, resulting in approximately 16,300,795 shares outstanding post-split. Fractional shares will be paid cash in lieu, and all outstanding stock options and warrants will be proportionally adjusted.

auto_awesomeAnalysis

Quince Therapeutics is proceeding with a 1-for-10 reverse stock split, a move often undertaken by companies with low stock prices to meet exchange listing requirements and potentially attract a broader investor base. While the authorization for this split was previously disclosed in June 2025, this filing marks the definitive implementation, setting the effective date and the start of split-adjusted trading. This action, while necessary for compliance, typically carries a negative sentiment as it does not alter the company's underlying value and can sometimes be perceived as a sign of financial distress.